Why are women more at risk of adrenal cancer?
Cancer types:
Adrenal cancer
Project period:
–
Research institute:
L'Institut national de la santé et de la recherche médicale, Marseille
Award amount:
£178,999.46
Location:
France
Dr Andreas Schedl aims to understand the basic processes of why women are more likely to have adrenal cancer. Uncovering these mechanisms might help to develop sex-specific treatments or preventative strategies in the future.
Meet the scientist
Dr Andreas Schedl works at INSERM where he co-founded the Instiute de Biologie Valrose. He and his team are focusing on understanding cell development and maintenance and their link to cancer in kidneys and adrenal glands.
The science
Adrenocortical cancers (tumours of the adrenal gland) are a rare but highly aggressive disease. In mice and humans there is a clear sex bias with females approximately three times more likely to develop this cancer than males. The biological basis for this sex difference is unclear, but an understanding of the molecular processes responsible might help develop sex-specific treatments or preventive strategies.
Dr Andreas Schedl and his team at INSERM, France, have developed a mouse model of adrenal cancer which shows similar sex-difference patterns of cancer seen in humans. They now want to use this mouse model to work out what is going on at a molecular level in the adrenal that causes this difference. They are particularly interested in the processes that cause stem cells within the adrenal to divide uncontrollably.
Active United Kingdom
Bowel cancer
With your support, Professor Lesley Stark and her team in Edinburgh hope to find new ways to prevent cancer linked to ageing. This has huge potential to reveal new approaches to cancer treatment or to prevent it developing in older people.
Researcher: Professor Lesley Stark
Journey to the centre of a cell: why does age matter in cancer?
Active Netherlands
Leukaemia
Thanks to our Curestarters, Professor Delwel and his team in the Netherlands hope to find a much-needed new leukaemia cure. Acute Myeloid Leukaemia (AML) can sometimes be caused by a specific gene, so by better understanding this gene we can look for new cures.
Researcher: Professor Ruud Delwel
Mission impossible: how can we target “Evi1” leukaemias?
Active Netherlands
Bowel cancer
Dr Schuijers and his team in the Netherlands are using Curestarter funding to look for new bowel cancer cures. The team think that disrupting certain 'droplets' could be a powerful new way to stop cancer.
Researcher: Dr Jurian Schuijers
Could targeting tiny droplets inside cells help to treat bowel cancer?